PITAVASTATIN

Basic Information

Item Value
DrugBank ID DB08860
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 50

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
2 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
3 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
4 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
5 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
6 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
7 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
8 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
9 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
10 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
11 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
12 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
13 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
14 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
15 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
16 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
17 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
18 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
19 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
20 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
21 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
22 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
23 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
24 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
25 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
26 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
27 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
28 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
29 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
30 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
31 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
32 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
33 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
34 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
35 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
36 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
37 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
38 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
39 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
40 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
41 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
42 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
43 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
44 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
45 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
46 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
47 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
48 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph
49 hyperlipidemia, familial combined, LPL related TxGNN Knowledge Graph
50 obsolete familial combined hyperlipidemia TxGNN Knowledge Graph

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search